Justin Kim

Stock Analyst at Oppenheimer

(1.51)
# 3,475
Out of 5,044 analysts
37
Total ratings
41.38%
Success rate
-7.89%
Average return

Stocks Rated by Justin Kim

Zura Bio
Aug 15, 2025
Maintains: Outperform
Price Target: $17$16
Current: $3.77
Upside: +324.40%
Apellis Pharmaceuticals
Nov 6, 2024
Maintains: Outperform
Price Target: $65$40
Current: $30.05
Upside: +33.11%
Pharvaris
Sep 6, 2024
Maintains: Outperform
Price Target: $38$42
Current: $22.65
Upside: +85.43%
Cytokinetics
May 9, 2024
Maintains: Outperform
Price Target: $107$106
Current: $61.97
Upside: +71.05%
Immunocore Holdings
Feb 29, 2024
Reiterates: Outperform
Price Target: $85$87
Current: $33.75
Upside: +157.78%
Vera Therapeutics
Jan 25, 2024
Initiates: Outperform
Price Target: $26
Current: $29.96
Upside: -13.22%
Aldeyra Therapeutics
Oct 17, 2023
Downgrades: Perform
Price Target: n/a
Current: $5.14
Upside: -
Aurinia Pharmaceuticals
Nov 4, 2022
Downgrades: Perform
Price Target: n/a
Current: $12.63
Upside: -
BioCryst Pharmaceuticals
Aug 8, 2022
Downgrades: Perform
Price Target: n/a
Current: $7.24
Upside: -
Ionis Pharmaceuticals
Jul 18, 2022
Assumes: Outperform
Price Target: $59
Current: $73.57
Upside: -19.80%